6,176
Views
27
CrossRef citations to date
0
Altmetric
Original Research

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis

, , , &
Pages 815-824 | Received 11 Apr 2019, Accepted 25 Jun 2019, Published online: 09 Jul 2019

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.